Baclofen-Induced Encephalopathy in End Stage Renal Disease
Baclofen is a highly used centrally acting GABA agonist that continues to be an effective therapy for spasticity and chronic hiccups. The renally dependent excretion determines the circulating concentrations and guides effective dosing to decrease adverse reactions. Caution should be considered in a...
Saved in:
| Main Authors: | Andrew Meillier, Cara Heller, Shyam Patel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2015/203936 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bruxism Associated with Anoxic Encephalopathy: Successful Treatment with Baclofen
by: A. Bruce Janati, et al.
Published: (2013-01-01) -
Acute Cyanide Poisoning: Hydroxocobalamin and Sodium Thiosulfate Treatments with Two Outcomes following One Exposure Event
by: Andrew Meillier, et al.
Published: (2015-01-01) -
Recurrent Posterior Reversible Encephalopathy Syndrome in an Adolescent Boy with End-Stage Renal Disease
by: Andrew Shieh, et al.
Published: (2021-01-01) -
Baclofen-induced pancreatitis
by: Nicolas Nassif, et al.
Published: (2025-04-01) -
Metronidazole-Induced Encephalopathy in a Patient with End-Stage Liver Disease
by: John P. Knorr, et al.
Published: (2012-01-01)